![Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition]()
Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibitionWill Spooren; Cedric Mombereau; Martine Maco; Rammy Gill; John A. Kemp; Laurence Ozmen; Shigetada Nakanishi; Guy A. Higgins · 2004